Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria

doi: 10.5694/mja2.51667.

Online ahead of print.


Item in Clipboard

Laura Bywater et al.

Med J Aust.


No abstract available


Bone marrow diseases; Cardiomyopathies; Echocardiography; Glomerulonephritis; Heart failure; Kidney diseases; Myeloma; Ventricular dysfunction.


    1. Gertz MA. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment. Am J Hematol 2018; 93: 1169-1180.

    1. van Gameren II, Hazenberg BP, Bijzet J, et al. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 2006; 54: 2015-2021.

    1. Muchtar E, Derudas D, Mauermann M, et al. Systemic immunoglobulin light chain amyloidosis-associated myopathy: presentation, diagnostic pitfalls, and outcome. Mayo Clin Proc 2016; 91: 1354-1361.

    1. Gibbs S, Mollee P. Clinical practice guideline: systemic AL amyloidosis. Medical Scientific Advisory Group to Myeloma Australia (updated Sept 2019). https://myeloma.org.au/wp-content/uploads/2021/11/MSAG-Clinical-Practice… (viewed June 2021).

    1. Hester LL, Gifkins DM, Bellew KM, et al. Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019. Eur J Haematol 2021; 107: 428-435.

Source link

Back to top button